2nd TGF-β for Immuno-Oncology Drug Development Summit
Evvnt Promotion / evvnt
Archivio

25.01.2022 - 27.01.2022 Online, USA
Time: 9:00 AM - 5:00 PM
Temi della conferenza
From Cell Signaling to the Tumor Microenvironment, Exploit TGF-β’s Role in IO to Harness a Clinically Relevant, Safe & Efficacious Therapeutics
It is clear the world of TGF-β contains vast potential and excitement, in the past year alone we have seen great advances, clinical setbacks, and novel insights into the role of TGF-β.
From Cell Signaling to the Tumor Microenvironment, Exploit TGF-β’s Role in IO to Harness a Clinically Relevant, Safe & Efficacious Therapeutics
It is clear the world of TGF-β contains vast potential and excitement, in the past year alone we have seen great advances, clinical setbacks, and novel insights into the role of TGF-β.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Informazioni ed Iscrizioni:
https://go.evvnt.com/913463-1?pid=4832
Ms. Erin Thomas
Oncologia
Lingua
Inglese
Inglese
Quote del Congresso
USD 599.00 - USD 3598.00
USD 599.00 - USD 3598.00
I partecipanti attesi
1000
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."